
Opinion|Videos|April 1, 2024
Key Takeaways Regarding Operationalizing Bispecific Antibodies for MM
Panelists summarize key takeaways on using bispecific antibodies for multiple myeloma treatment.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Early Recognition and Routine Discussion: Improving Outcomes in Tardive Dyskinesia
2
Meet the FDA’s Newly Approved OTC Sunscreen Ingredient: Bemotrizinol
3
Do GLP-1 Receptor Agonists Increase the Risk of Smell and Taste Disturbances?
4
Melatonin May Reduce Musculoskeletal Pain and Improve Sleep
5












































































































